News|Articles|August 5, 2026

Presenting Our August 2026 Theme: Suicide

Author(s)Leah Kuntz
Listen
0:00 / 0:00

Key Takeaways

  • Contributions are requested that address how psychopharmacology can be leveraged to reduce suicide risk across clinical settings.
  • Common treatment barriers in patients expressing suicidal thoughts are highlighted as a priority area for shared clinical experience.
SHOW MORE

Explore suicide prevention in psychiatry—risk assessment, treatment challenges, and emerging research. Submit your case or CME for August 2026.

Psychiatric Times features monthly themes that speak to various aspects of psychiatry and issues relevant to psychiatric clinicians. Our August 2026 theme focuses on suicide.

Suicide is the 10th leading cause of death in the United States, with approximately 48,824 Americans dying by suicide in 2024 and 2.2 million attempts.1

How can we leverage psychopharmacology to prevent suicide? What challenges do you believe are most prevalent when treating a patient expressing suicidal thoughts? How do you best assess suicide risk? What research in suicidality are you most interested in? Do you have practice tips to offer your fellow mental health clinicians? Have you experienced a patient case that could help others learn?

If you have something you want to share, whether that's an article, case study example, or CME article, let us know! Write to us now at [email protected] to be featured in our August content series and potentially in a future Special Report/print issue.

Example articles include:

Assessment of Suicide Risk in Individuals With Schizophrenia

Comparing SSRI Treatment and DBT for Managing Suicidality in Patients With Borderline Personality Disorder

Requiring AI-Driven Suicide Risk Stratification in Emergency Settings: Helpful or Risky?

Accident, or Is It? The Watershed Area Between Trauma and Suicide

Reference

1. Suicide statistics. AFSP. Accessed August 5, 2026. https://afsp.org/suicide-statistics/


Latest CME